Camilla Dalby Hansen

Author

Also Known As

Camilla Dalby Hansen, Camilla D Hansen, Camilla D. Hansen, Camilla Dalby Hansen, Camilla Dalby-Hansen, Camilla Hansen, Dalby Hansen, Camilla, Hansen, Camilla Dalby, Hansen, Camilla Franziska, Huang, W.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital University of Southern Denmark University of Copenhagen Novo Nordisk Foundation Steno Diabetes Centers

About

Camilla Dalby Hansen is an author at Odense University Hospital specializing in medicine, liver physiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	519
2	Hepatology	4	4	382
3	Health Sciences	3	3	357
4	Epidemiology	2	2	309
5	Biochemistry	1	1	48

Camilla Dalby Hansen

Publications

Citations

H-Index

Page 1

	Year	Citations
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease Maria Kjærgaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, Journal of Hepatology EpidemiologyHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyNafld Fibrosis Score	2023	178
Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis Han Gao, Matt C. Danzi, Claire Choi, Cell Reports Macrophagic Tnfr2Tnf Receptor 2ImmunologyImmune RegulationCell Death	2017	137
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study Mads Israelsen, Nikolaj Torp, Stine Johansen, The Lancet. Gastroenterology & hepatology Excessive Alcohol IntakeSubstance AbuseMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2024	131
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Camilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, Annals of Internal Medicine	2022	98
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial Mads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp, The Lancet. Gastroenterology & hepatology	2023	70
Effects of a 6‐month, low‐carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open‐label randomized controlled trial Eva-Marie Gram-Kampmann, Camilla Dalby Hansen, Mie Balle Hugger, Diabetes Obesity and Metabolism	2022	57
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness Vineesh Indira Chandran, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen, Hepatology	2022	50
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication Mads Israelsen, Min Kim, Tommi Suvitaival, JHEP Reports Substance AbuseHepatologyBiochemistryNonalcoholic Fatty Liver DiseaseMetabolic Associated Steatotic Liver Disease	2021	48
Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals Maria Kjærgaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, Clinical Gastroenterology and Hepatology	2023	47
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease Katrine Holtz Thorhauge, Georg Semmler, Stine Johansen, Journal of Hepatology	2024	35

Page 1